Pamela S. Herrera
- Immunology top 10%
-
- CAR-T cell therapy research 2
- Neutropenia and Cancer Infections 1
-
- Cancer, Hypoxia, and Metabolism 1
-
- CRISPR and Genetic Engineering 2
- Pluripotent Stem Cells Research 1
- Retinal Development and Disorders 1
-
- Genomics and Rare Diseases 1
- Diabetes and associated disorders 1
- Co-authors
- Marcel R.M. van den BrinkMadeline A. HweeAnsuman T. SatpathyMelody SmithKathryn E. YostSantosha A. VardhanaBryan H. KingMirela Berisa
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United States
In The Last Decade
Pamela S. Herrera
8 papers receiving 406 citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Immunology 226
- Oncology 166
- Cancer Research 65
- Biological Psychiatry 8
- Ophthalmology 23
Countries citing papers authored by Pamela S. Herrera
This map shows the geographic impact of Pamela S. Herrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela S. Herrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela S. Herrera more than expected).
Fields of papers citing papers by Pamela S. Herrera
This network shows the impact of papers produced by Pamela S. Herrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela S. Herrera. The network helps show where Pamela S. Herrera may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pamela S. Herrera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2021 | 1 | |
| 4 | Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigenbreakdown → | 2020 | 343 |
| 5 | 2018 | 38 | |
| 6 | 2018 | 23 | |
| 7 | 2015 | 1 | |
| 8 | Evaluación de un modelo de intervención para fomentar estilos de vida saludables en preescolares | 2000 | 2 |
About Pamela S. Herrera
Pamela S. Herrera is a scholar working on Clinical Biochemistry, Ophthalmology and Oncology, having authored 8 papers that have together received 411 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers), Genomics and Rare Diseases (1 paper), Neutropenia and Cancer Infections (1 paper), Pluripotent Stem Cells Research (1 paper), Diabetes and associated disorders (1 paper), Retinal Development and Disorders (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Immunology (226 citations), Oncology (166 citations) and Cancer Research (65 citations). Pamela S. Herrera has collaborated with scholars based in United States. Frequent co-authors include Marcel R.M. van den Brink, Madeline A. Hwee, Ansuman T. Satpathy, Melody Smith, Kathryn E. Yost, Santosha A. Vardhana, Bryan H. King, Mirela Berisa, Howard Y. Chang and Craig B. Thompson. Their work appears in journals such as Blood, Nature Immunology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.